Prime Medicine Inc (PRME)

$3.70 +0.13 (3.64%)
Market Cap 637.20M
Revenue (ttm) 2.98M
Net Income (ttm) -195.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,573.15%
Debt to Equity Ratio 0.00
Volume 4,287,700
Avg Vol 3,842,250
Day's Range N/A - N/A
Shares Out 180.51M
Stochastic %K 71%
Beta 2.71
Analysts Strong Sell
Price Target $6.41

Company Profile

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and peg...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 465 0013
Address:
60 First Street, Cambridge, United States
Wax_Bean_futures
Wax_Bean_futures Jan. 7 at 12:48 AM
$UPST Let's see how the market reacts on Friday. $TE $PSNL $PRME $IREN https://www.reuters.com/legal/government/with-trumps-tariffs-line-us-supreme-court-plans-rulings-friday-2026-01-06/
0 · Reply
babyloncapital
babyloncapital Jan. 6 at 8:46 PM
$PRME trapped in sma convergence should move one way or another soon.
0 · Reply
TooPoorForPennyStocks
TooPoorForPennyStocks Jan. 6 at 6:33 PM
$PRME Right on que @someguytrades
0 · Reply
PorkchopSquats
PorkchopSquats Jan. 6 at 6:15 PM
$PRME Backtest or false breakout? Watch but keep an open mind.
1 · Reply
someguytrades
someguytrades Jan. 6 at 6:02 PM
$PRME everyone knew it was going to give it up, right?
1 · Reply
arg195
arg195 Jan. 6 at 6:02 PM
$PRME where are you at? 😂😂😂
1 · Reply
Elamenape2
Elamenape2 Jan. 6 at 5:52 PM
$PRME
0 · Reply
someguytrades
someguytrades Jan. 6 at 5:41 PM
$PRME closing red again for no reason 😂😂😂 remarkably weak
0 · Reply
___IFindKarma___
___IFindKarma___ Jan. 6 at 4:44 PM
$PRME back in for a swing as this may have bottomed…again. Will 2026 be an advancing year for cures via gene editing rather than just throwing drugs at everything? Will see.
0 · Reply
Elamenape2
Elamenape2 Jan. 6 at 4:12 PM
$PRME
0 · Reply
Latest News on PRME
Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond

Dec 31, 2025, 1:29 PM EST - 6 days ago

Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Dec 7, 2025, 8:05 AM EST - 4 weeks ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 8:00 AM EST - 6 weeks ago

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript

Nov 12, 2025, 2:51 PM EST - 7 weeks ago

Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript

Prime Medicine to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 8:00 AM EST - 2 months ago

Prime Medicine to Present at Jefferies Global Healthcare Conference

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 7, 2025, 10:21 AM EST - 2 months ago

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 7, 2025, 7:00 AM EST - 2 months ago

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Nov 3, 2025, 8:01 AM EST - 2 months ago

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

Oct 30, 2025, 4:01 PM EDT - 2 months ago

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

Prime Medicine to Participate in Upcoming Investor Conferences

Oct 7, 2025, 8:00 AM EDT - 3 months ago

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 5:38 PM EDT - 4 months ago

Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Prime Medicine, Inc. (PRME) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 8:07 PM EDT - 4 months ago

Prime Medicine, Inc. (PRME) Presents At Citi's Biopharma Back To School Conference Transcript

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Aug 1, 2025, 4:01 PM EDT - 5 months ago

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Prime Medicine Announces Pricing of Public Offering

Jul 30, 2025, 9:33 PM EDT - 5 months ago

Prime Medicine Announces Pricing of Public Offering

Prime Medicine Announces Proposed Public Offering of Common Stock

Jul 30, 2025, 4:01 PM EDT - 5 months ago

Prime Medicine Announces Proposed Public Offering of Common Stock

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

Jul 16, 2025, 8:10 AM EDT - 6 months ago

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Jul 16, 2025, 7:00 AM EDT - 6 months ago

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Prime Medicine: Pressing Forward With Lead Liver Targeting Indications

Jul 7, 2025, 4:45 PM EDT - 6 months ago

Prime Medicine: Pressing Forward With Lead Liver Targeting Indications

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

May 19, 2025, 8:31 AM EDT - 8 months ago

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

May 19, 2025, 8:30 AM EDT - 8 months ago

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

May 8, 2025, 8:00 AM EDT - 8 months ago

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Mar 18, 2025, 7:00 AM EDT - 10 months ago

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Feb 28, 2025, 8:00 AM EST - 11 months ago

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Feb 24, 2025, 8:00 AM EST - 11 months ago

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Jan 30, 2025, 12:26 PM EST - 1 year ago

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies

Nov 26, 2024, 5:10 AM EST - 1 year ago

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies

BMY

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics

Nov 21, 2024, 4:18 AM EST - 1 year ago

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Oct 24, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher

Sep 30, 2024, 12:17 PM EDT - 1 year ago

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline

Sep 30, 2024, 8:38 AM EDT - 1 year ago

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline

BMY

Prime Medicine Unveils Strategically Focused Pipeline

Sep 30, 2024, 7:01 AM EDT - 1 year ago

Prime Medicine Unveils Strategically Focused Pipeline

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Alphabet Bought Up Two Slumping Stocks

May 12, 2024, 3:00 AM EDT - 1 year ago

Alphabet Bought Up Two Slumping Stocks

GOOG GOOGL GTLB

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

May 10, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

May 8, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Apr 29, 2024, 7:00 AM EDT - 1 year ago

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

Apr 23, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

Mar 1, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 20, 2024, 4:01 PM EST - 2 years ago

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Prime Medicine Announces Pricing of Upsized Public Offering

Feb 14, 2024, 11:50 PM EST - 2 years ago

Prime Medicine Announces Pricing of Upsized Public Offering

Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing

Jan 28, 2024, 8:11 AM EST - 2 years ago

Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

Jan 25, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Jan 25, 2024, 8:00 AM EST - 2 years ago

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Jan 5, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 8:00 AM EST - 2 years ago

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

AI In Biotech: A Revolutionary Leap Forward Or Just Another Buzzword?

Dec 1, 2023, 2:45 PM EST - 2 years ago

AI In Biotech: A Revolutionary Leap Forward Or Just Another Buzzword?

CRSP

Prime Medicine to Present at Upcoming Investor Conferences

Nov 8, 2023, 8:00 AM EST - 2 years ago

Prime Medicine to Present at Upcoming Investor Conferences

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 3, 2023, 4:01 PM EDT - 2 years ago

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates

Wax_Bean_futures
Wax_Bean_futures Jan. 7 at 12:48 AM
$UPST Let's see how the market reacts on Friday. $TE $PSNL $PRME $IREN https://www.reuters.com/legal/government/with-trumps-tariffs-line-us-supreme-court-plans-rulings-friday-2026-01-06/
0 · Reply
babyloncapital
babyloncapital Jan. 6 at 8:46 PM
$PRME trapped in sma convergence should move one way or another soon.
0 · Reply
TooPoorForPennyStocks
TooPoorForPennyStocks Jan. 6 at 6:33 PM
$PRME Right on que @someguytrades
0 · Reply
PorkchopSquats
PorkchopSquats Jan. 6 at 6:15 PM
$PRME Backtest or false breakout? Watch but keep an open mind.
1 · Reply
someguytrades
someguytrades Jan. 6 at 6:02 PM
$PRME everyone knew it was going to give it up, right?
1 · Reply
arg195
arg195 Jan. 6 at 6:02 PM
$PRME where are you at? 😂😂😂
1 · Reply
Elamenape2
Elamenape2 Jan. 6 at 5:52 PM
$PRME
0 · Reply
someguytrades
someguytrades Jan. 6 at 5:41 PM
$PRME closing red again for no reason 😂😂😂 remarkably weak
0 · Reply
___IFindKarma___
___IFindKarma___ Jan. 6 at 4:44 PM
$PRME back in for a swing as this may have bottomed…again. Will 2026 be an advancing year for cures via gene editing rather than just throwing drugs at everything? Will see.
0 · Reply
Elamenape2
Elamenape2 Jan. 6 at 4:12 PM
$PRME
0 · Reply
arg195
arg195 Jan. 6 at 4:07 PM
$PRME here bruh
1 · Reply
TooPoorForPennyStocks
TooPoorForPennyStocks Jan. 6 at 3:54 PM
$PRME Where dis bitch at?
0 · Reply
PorkchopSquats
PorkchopSquats Jan. 6 at 3:43 PM
$PRME Gorgeous first hourly candle of the day breaking out.
1 · Reply
burbs88
burbs88 Jan. 6 at 3:13 PM
$PRME Plenty of room to run.
0 · Reply
sogenerous
sogenerous Jan. 6 at 3:03 PM
$PRME 3.9-4s possible today
1 · Reply
Elamenape2
Elamenape2 Jan. 6 at 2:51 PM
$PRME $BEAM Going crazy!
0 · Reply
Elamenape2
Elamenape2 Jan. 6 at 2:47 PM
$PRME https://seekingalpha.com/article/4856580-prime-maintaining-buy-on-solidified-catalysts-for-wilsons-disease-and-beyond
0 · Reply
Mcnulty_jimmy
Mcnulty_jimmy Jan. 6 at 2:43 PM
$PRME Daily Deion
0 · Reply
PorkchopSquats
PorkchopSquats Jan. 6 at 2:24 PM
$PRME Daily chart. Not my base case, but worth looking any bearish indications that may be present. One head and shoulders seems to have failed, but there is a potential second forming right now as well. I still lean heavily bullish, but keeping an eye out.
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jan. 6 at 2:18 PM
$TERN $ALMS $PRME $ALT $CAPR 2 month check up. How am I doing?
5 · Reply
Mcnulty_jimmy
Mcnulty_jimmy Jan. 5 at 10:43 PM
$PRME Would like an update of some kind before the conference on the 14th
0 · Reply
TooPoorForPennyStocks
TooPoorForPennyStocks Jan. 5 at 8:37 PM
$PRME Bitch falling over himself trying to find a bearish narrative here. Double bottomed at the 200 SMA and buyers casually swallowing every drop the last three sessions. Come 2027 this dude is gonna look certifiably retarded for missing out on what is coming.
1 · Reply